Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)

Abstract Background Immune checkpoint inhibitors (ICIs) show optimal treatment effects on recurrent or metastatic nasopharyngeal carcinoma(R/M NPC). Nonetheless, whether metastatic sites impact ICIs efficacy remains unclear. Methods We performed a secondary analysis of R/M NPC patients treated with...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yuantai Li, Yu Min, Zhigong Wei, Zheran Liu, Yiyan Pei, Yujie Yang, Kun Gao, Ge Song, Shihong Xu, Shuangshuang He, Junyou Ge, Yan Qing, Youneng Wei, Ping Ai, Ye Chen, Xingchen Peng
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Springer 2025-01-01
Цуврал:	Cancer Immunology, Immunotherapy
Нөхцлүүд:	Metastatic sites Nasopharyngeal carcinoma Anti-PD-L1 Survival
Онлайн хандалт:	https://doi.org/10.1007/s00262-024-03905-0
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!